ARDT – ardent health partners, inc. (US:NASDAQ)

News

Ardent Health Appoints Dave Styblo to Lead Investor Relations
Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Ardent Health Reports Second Quarter 2024 Results
Ardent Health Partners, LLC (NYSE: ARDT) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ardent Health Partners, LLC (NYSE: ARDT) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $22.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com